ESElvia Harumi Scott-López

Elvia Harumi Scott-López

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elvia Harumi Scott-López has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Adriana Aguilar-Lemarroy

    Unidad de Investigación Epidemiológica y en Servicios de Salud, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Ana María Puebla-Pérez

    Laboratorio de Inmunofarmacología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara (UdeG), Guadalajara 44430, Jalisco, Mexico

    1 shared publication
  • Arnulfo Hernán Nava-Zavala

    Unidad de Investigacion Epidemiologica y en Servicios de Salud, Centro Medico Nacional de Occidente Organo de Operación Administrativa Desconcentrada Jalisco, Instituto Mexicano del Seguro Social, Guadalajara 44329, Jalisco, Mexico

    1 shared publication
  • Asbiel Felipe Garibaldi-Ríos

    División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Augusto Sarralde-Delgado

    Coordinador Auxiliar Médico de Investigación en Salud, Coordinación de Planeación y Enlace Institucional, OOAD Jalisco, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Belinda Claudia Gómez-Meda

    Instituto de Genética Humana “Dr. Enrique Corona Rivera”, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico

    1 shared publication

Latest Publications

  • Open Access

    Blood Lead Levels and Associated Sociodemographic and Occupational Factors in Children from Two Mexican Communities: A Comparative Study

    by Jesús García-Gómez, Oscar Humberto Rodríguez-Aguirre, Jorge Adrian Ruíz-Romero, Elvia Harumi Scott-López, Erick Jonathan Becerra-Iñiguez, María Claudia Espinel-Bermúdez, Arnulfo Hernán Nava-Zavala, Adriana Aguilar-Lemarroy, Augusto Sarralde-Delgado, Luis Felipe Jave-Suárez

    Lead is a neurotoxic metal. No safe blood lead level (BLL) has been identified in children; the CDC reference value was lowered to 3.5 µg/dL in 2021, while Mexico’s regulatory threshold remains at 10 µg/dL. Lead-glazed earthenware is the main documented source of pediatric exposure in Mexico. We studied children 0–15 years insured by the Mexican Social Security Institute (IMSS) in two Jalisco municipalities: Tonalá (n = 500), historically a ceramic-producing center, and Zapopan (n = 374), an urban area without this tradition. BLL was measured by graphite furnace atomic absorption spectrophotometry, and sociodemographic, environmental, occupational, and household exposure data were collected by questionnaire and analyzed with bivariate tests and multivariable models. Median BLL was 1.16 µg/dL in Tonalá and 2.08 µg/dL in Zapopan. Few children reached 5 µg/dL (3.2% and 6.4%), roughly twice as many exceeded 3.5 µg/dL (6.6% and 16.3%), and most exceeded 1 µg/dL (59.4% and 93.6%). In Zapopan, household glazed earthenware use and younger age were independently associated with a higher BLL in every model; in Tonalá, paternal professional occupation was associated with a lower BLL, an exploratory finding given its small subgroup. Widespread low-level exposure at both sites supports sustained facility-level surveillance and alignment of Mexico’s regulatory criterion with current reference values.

  • Open Access

    Lead Poisoning in the Americas: Sources, Regulations, Health Impacts, and Molecular Mechanisms

    by Blanca Miriam Torres-Mendoza, Asbiel Felipe Garibaldi-Ríos, Lourdes Del Carmen Rizo De La Torre, Ana María Puebla-Pérez, Luis E. Figuera, Guillermo Moisés Zúñiga-González, Belinda Claudia Gómez-Meda, Itzae Adonai Gutiérrez-Hurtado, Elvia Harumi Scott-López, Verónica Vázquez-González, et al.

    Lead poisoning is a significant public health issue, contributing to 0.6% of the global disease burden and disproportionately affecting developing countries. Vulnerable populations, such as children, pregnant women, and low-income communities, remain at high risk, often exposed to lead levels exceeding safe thresholds. While the problem is global, this review focuses specifically on the Americas, regions with diverse regulatory landscapes and persistent environmental lead exposure. Regulatory frameworks vary widely, and the lack of global consensus on acceptable blood lead levels leaves important gaps in protection. This review compiles and updates knowledge on emerging sources of lead exposure in the region, evaluates advancements in regulatory approaches, and analyzes the molecular impacts of lead on human health. Using the Comparative Toxicogenomics Database (CTD), lead was found to interact with 3448 genes, including those linked to inflammation and oxidative stress, and is associated with 4401 diseases and 799 disrupted pathways. These findings emphasize the need for regionally tailored interventions, strengthened policies, and further research on its health impacts.